Articles published in Journal of Next Generation Sequencing & Applications have been cited by esteemed scholars and scientists all around the world. Journal of Next Generation Sequencing & Applications has got h-index 10, which means every article in Journal of Next Generation Sequencing & Applications has got 10 average citations.
Following are the list of articles that have cited the articles published in Journal of Next Generation Sequencing & Applications.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
0 | 31 | 27 | 0 | 1 |
Year wise citations received |
81 | 96 | 113 | 87 | 65 |
| Journal total citations count | 655 |
| Journal impact factor | 5.42 |
| Journal 5 years impact factor | 7.34 |
| Journal cite score | 6.34 |
| Journal h-index | 10 |
| Journal h-index since 2018 | 8 |
| Journal Impact Factor 2020 formula |
| IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year |
| Journal 5-year Impact Factor 2020 formula |
| Citations(2016 + 2017 + 2018 + 2019 + 2020)/ {Published articles(2016 + 2017 + 2018 + 2019 + 2020)} |
| Journal citescore |
| Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3 |
Venkatesan S, Birkbak NJ, Swanton C (2017) Constraints in cancer evolution. Biochemical Society Transactions. 45:1-3. |
|
Zechner D, Bürtin F, Albert AC, Zhang X, Kumstel S, et al.(2016) Intratumoral heterogeneity of the therapeutical response to gemcitabine and metformin. Oncotarget 756395. |
|
Kimani SG, Kumar S, Bansal N, Singh K, Kholodovych V, et al (2017 ) Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicity. Scientific reports 7: 43908. |
|
Luz FA, BrÃgido PC, Moraes AS, Silva MJ (2017) Aberrant splicing in cancer: Mediators of malignant progression through an imperfect splice program shift. Oncology 92: 3-13. |
|
Ciavatta ML, Lefranc F, Carbone M, Mollo E, Gavagnin M, Betancourt T, et al (2017 ) Marine Molluskâ€Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance. Medicinal research reviews 37: 702-801. |
|
Efferth T, Saeed ME, Mirghani E, Alim A, Yassin Z,et al (2017 ) Integration of phytochemicals and phytotherapy into cancer precision medicine. Oncotarget 8: 50284. |
|
Greene SB, Dago AE, Leitz LJ, Wang Y, Lee J,et al (2016) Chromosomal instability estimation based on next generation sequencing and single cell genome wide copy number variation analysis. PloS one 11: 0165089. |
|
FriedmanR (2016 ) Drug resistance in cancer: molecular evolution and compensatory proliferation. Oncotarget 7: 11746. |
|
Li YH, Yu CY, Li XX, Zhang P, Tang J, et al (2017 ) Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics. Nucleic acids research 46: 1121-1127. |
|
Hu Z, Sun R, Curtis C (2017 ) A population genetics perspective on the determinants of intra-tumor heterogeneity. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1867: 109-126. |
|
Marum JE, Branford S (2016 ) Current developments in molecular monitoring in chronic myeloid leukemia. Therapeutic advances in hematology 7: 237-251. |
|
Terenzi A, Pirker C, Keppler BK, Berger W (2016) Anticancer metal drugs and immunogenic cell death. Journal of inorganic biochemistry 165: 71-79. |
|
Penault-Llorca F, Radosevic-Robin N (2016 ) Biomarkers of residual disease after neoadjuvant therapy for breast cancer. Nature Reviews Clinical Oncology 13: 487. |
|
Passaro A, Guerini-Rocco E, Pochesci A, Vacirca D, Spitaleri G, et al. (2017 ) Targeting EGFR T790M mutation in NSCLC: From biology to evaluation and treatment. Pharmacological research 117: 406-415. |
|
Ganai RA, Johansson E (2016 ) DNA replication—a matter of fidelity. Molecular cell. 62: 745-755. |
|
Kortüm KM, Mai EK, Hanafiah NH, Shi CX, Zhu YX, et al.(2016 ) Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes. Blood. |
|
Lee G, Lee HY, Park H, Schiebler ML, van Beek EJ, et al (2017) Radiomics and its emerging role in lung cancer research, imaging biomarkers and clinical management: state of the art. European journal of radiology 86: 297-307. |
|
Denisenko TV, Sorokina IV, Gogvadze V, Zhivotovsky B (2016 ) Mitotic catastrophe and cancer drug resistance: A link that must to be broken. Drug resistance updates 24: 1-2. |
|
Lopez JS, Banerji U (2017 ) Combine and conquer: challenges for targeted therapy combinations in early phase trials. Nature reviews Clinical oncology 14: 57. |
|
Kalia A (2018 ) Nanotechnology in Bioengineering: Transmogrifying Plant Biotechnology. In Omics Technologies and Bio-Engineering pp.211-229. |
|
